Andra AP fonden Grows Stake in McDonald's Corporation $MCD
π Andra AP fonden raised its MCD stake by 995.1% in Q1, adding 79,211 shares to a total holding of 87,171 shares.
π Institutional ownership remains high at 70.29%, with Park Place Capital Corp and DecisionPoint Financial LLC also increasing positions significantly.
π° MCD stock trades at $267.50 with a market cap of $190.06 billion and a P/E ratio of 22.05.
π Insider selling occurred recently as Joseph M. Erlinger sold 5,252 shares and Desiree Ralls-Morrison sold 2,763 shares.
π΅ The company pays a quarterly dividend of $1.86, resulting in an annualized yield of 2.8%.
π― Analyst consensus is a 'Moderate Buy' with an average price target of $336.32 from MarketBeat data.
π Weiss Ratings lowered the stock rating from 'hold (c+)' to 'hold (c)' on June 23rd.
π Barclays reduced its price target from $380.00 to $350.00 while maintaining an 'overweight' rating.
π Tigress Financial lifted its price objective to $390.00 and reaffirmed a 'buy' rating.
π’ The company operates a global franchise system serving customers through dine-in, drive-thru, and digital platforms.
- Andra AP fonden increased its position by 995.1% in Q1, signaling strong institutional confidence in the company's long-term prospects.
- Park Place Capital Corp boosted its stake by 95.7%, and DecisionPoint Financial LLC grew holdings by 1,616.7%, indicating renewed hedge fund interest.
- The stock maintains a solid dividend yield of 2.8% with a payout ratio of 61.34%, providing reliable income to investors.
- Analyst consensus is 'Moderate Buy' with an average price target of $336.32, suggesting upside potential from current levels.
- Tigress Financial raised its price objective to $390.00 and issued a 'buy' rating, reflecting positive outlook on the business model.
- Insider selling activity is notable, with Joseph M. Erlinger reducing his stake by 40.44% and Desiree Ralls-Morrison by 30.59% in recent transactions.
- Weiss Ratings downgraded the stock from 'hold (c+)' to 'hold (c)', indicating a slight reduction in analyst confidence.
- Barclays lowered its price target from $380.00 to $350.00, suggesting some analysts see limited near-term upside.